Simultaneous pancreatectomy and liver transplantation: a single-institution experience.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2697897)

Published in HPB (Oxford) on May 01, 2009

Authors

Rajeev Dhupar1, Michael E de Vera, J Wallis Marsh, Paulo A Fontes, Jennifer L Steel, Herbert J Zeh, T Clark Gamblin

Author Affiliations

1: Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.

Articles cited by this

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91

Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl (2003) 3.11

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Hepatic transplantation for primary and metastatic cancers of the liver. Surgery (1991) 1.93

Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg (1990) 1.45

Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation (1998) 1.36

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg (1997) 1.29

Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27

Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet (1989) 1.17

Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl (2007) 1.06

Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology (2003) 1.03

Resection versus transplantation for liver metastases from neuroendocrine tumors. Transplant Proc (2001) 0.96

Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP (2006) 0.96

Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours. Best Pract Res Clin Gastroenterol (2005) 0.92

Primary and secondary hepatic manifestation of neuroendocrine tumors. Langenbecks Arch Surg (2000) 0.89

Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience. Transplant Proc (2001) 0.86

Treatment of hepatic metastases from gastroenteropancreatic neuroendocrine tumors: role of liver transplantation. World J Surg (2001) 0.82

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

World review of laparoscopic liver resection-2,804 patients. Ann Surg (2009) 5.96

Endogenous HMGB1 regulates autophagy. J Cell Biol (2010) 4.71

Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg (2013) 3.94

The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev (2007) 3.33

High-mobility group box 1 and cancer. Biochim Biophys Acta (2010) 3.11

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med (2009) 2.56

Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol (2007) 2.49

Masquerader: high mobility group box-1 and cancer. Clin Cancer Res (2007) 2.40

PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev (2012) 2.24

Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol (2008) 2.22

High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal (2011) 2.19

Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13

Laparoscopic major hepatectomy: an evolution in standard of care. Ann Surg (2009) 2.01

Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res (2011) 1.98

Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst (2012) 1.94

High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab (2011) 1.89

Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Arch Surg (2010) 1.85

Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Arch Surg (2009) 1.82

Robotic-assisted major pancreatic resection and reconstruction. Arch Surg (2010) 1.82

Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs (2009) 1.79

HMGB1 in cancer: good, bad, or both? Clin Cancer Res (2013) 1.79

Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Ann Surg (2009) 1.74

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer (2010) 1.70

Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series. Clin Transplant (2007) 1.70

Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era. Liver Transpl (2011) 1.63

Arginine and immunity. J Nutr (2007) 1.62

Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Clin Gastroenterol Hepatol (2009) 1.60

Laparoscopic liver surgery: Shifting the management of liver tumors. Hepatology (2006) 1.58

Feature Selection for Classification of SELDI-TOF-MS Proteomic Profiles. Appl Bioinformatics (2005) 1.56

Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol (2008) 1.52

Colorectal blowout from compressed air: case report. J Trauma (2002) 1.50

Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol (2010) 1.50

Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50

Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer. Ann Surg Oncol (2010) 1.48

A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res (2008) 1.48

An often overlooked diagnosis: imaging features of gallbladder cancer. J Am Coll Surg (2012) 1.47

NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells. Cancer Res (2012) 1.46

Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma. Ann Surg Oncol (2013) 1.46

The Frey procedure for chronic pancreatitis secondary to pancreas divisum. JAMA Surg (2013) 1.46

High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy. J Immunother (2007) 1.45

Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg (2014) 1.44

Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol (2012) 1.44

p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res (2012) 1.41

Anesthesia Management for Palliative Surgery of Massive Hepatic Metastatic Melanoma. A A Case Rep (2016) 1.39

Extrahepatic portal vein aneurysm--report of six patients and review of the literature. J Gastrointest Surg (2007) 1.36

The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Res (2005) 1.34

EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc (2010) 1.30

HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy (2010) 1.30

The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proc Natl Acad Sci U S A (2012) 1.30

Comparing the clinical and economic impact of laparoscopic versus open liver resection. Ann Surg Oncol (2009) 1.29

High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxid Redox Signal (2011) 1.27

Adherence to the medical regimen during the first two years after lung transplantation. Transplantation (2008) 1.26

Can laparoscopic pancreaticoduodenectomy be safely implemented? J Gastrointest Surg (2011) 1.25

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer. J Surg Oncol (2013) 1.24

250 robotic pancreatic resections: safety and feasibility. Ann Surg (2013) 1.23

Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl (2004) 1.22

Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology (2012) 1.21

Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol (2007) 1.21

Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg (2007) 1.19

Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol (2008) 1.18

Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis (2008) 1.18

Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18

Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression. Cancer Res (2012) 1.17

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer (2012) 1.16

Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg (2012) 1.14

Cytolytic cells induce HMGB1 release from melanoma cell lines. J Leukoc Biol (2006) 1.14

Laparoscopic liver resection for cancer. Future Oncol (2008) 1.14

Correlates and outcomes of fatigue among incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.13

Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol (2008) 1.12

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts. Mod Pathol (2013) 1.12

Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol (2012) 1.12

Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin Biol Ther (2005) 1.11

A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg (2014) 1.11

Spontaneous rupture of hepatic artery aneurysm associated with polyarteritis nodosa. Am Surg (2010) 1.10

Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J Hepatol (2008) 1.08

HMGB1 as an autophagy sensor in oxidative stress. Autophagy (2011) 1.08

Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer (2013) 1.08

High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J Immunol (2006) 1.07

Current approach to hepatocellular carcinoma. Surg Clin North Am (2010) 1.06